본문 바로가기

US · 21 CFR

21 CFR Part 610

General Biological Products Standards

eCFR, up to date as of 2026-11-12

조항 목차

  1. 610.1Tests prior to release required for each lot.
  2. 610.2Requests for samples and protocols; official release.
  3. 610.9Equivalent methods and processes.
  4. 610.10Potency.
  5. 610.12Sterility.
  6. 610.13Purity.
  7. 610.14Identity.
  8. 610.15Constituent materials.
  9. 610.16Total solids in serums.
  10. 610.17Permissible combinations.
  11. 610.18Cultures.
  12. 610.39Definitions.
  13. 610.40Test requirements.
  14. 610.41Donor deferral.
  15. 610.42Restrictions on use for further manufacture of medical devices.
  16. 610.44Use of reference panels by manufacturers of test kits.
  17. 610.46Human immunodeficiency virus (HIV) “lookback” requirements.
  18. 610.47Hepatitis C virus (HCV) “lookback” requirements.
  19. 610.50Date of manufacture for biological products.
  20. 610.53Dating periods for Whole Blood and blood components.
  21. 610.60Container label.
  22. 610.61Package label.
  23. 610.62Proper name; package label; legible type.
  24. 610.63Divided manufacturing responsibility to be shown.
  25. 610.64Name and address of distributor.
  26. 610.65Products for export.
  27. 610.67Bar code label requirements.
  28. 610.68Exceptions or alternatives to labeling requirements for biological products held by the Strategic National Stockpile.
표지·목차 원문

Authority:21 U.S.C. 321, 331, 351, 352, 353, 355, 360, 360c, 360d, 360h, 360i, 371, 372, 374, 381; 42 U.S.C. 216, 262, 263, 263a, 264.

Source:38 FR 32056, Nov. 20, 1973, unless otherwise noted.

출처: U.S. Office of the Federal Register / GPO — eCFR · U.S. federal government work — public domain (17 U.S.C. §105). eCFR is an editorial compilation, not an official legal edition of the CFR. · 수집일 2026-11-16

Weekly Newsletter

FDA·EU·식약처 실사 지적, 매주 받아 보세요

FDA·EMA·식약처의 새 지적과 조치를 공식 원문 링크와 함께 보내드립니다. 사이트에 새로운 기능이 생기면 함께 안내드립니다. 구독은 언제든 한 번의 클릭으로 해지할 수 있습니다.

이번 주 소식 먼저 보기

확인 메일의 버튼을 누르면 구독이 완료됩니다 · 언제든 해지할 수 있습니다